Dangos 1 - 5 canlyniadau o 5 ar gyfer chwilio 'Vibhuti Vyas (15055988)', amser ymholiad: 0.01e Mireinio'r Canlyniadau
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... gan Ibrahim Aldoss (15055961)

    Cyhoeddwyd 2025
    Awduron Eraill:
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... gan Ibrahim Aldoss (15055961)

    Cyhoeddwyd 2025
    Awduron Eraill:
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... gan Ibrahim Aldoss (15055961)

    Cyhoeddwyd 2025
    Awduron Eraill:
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... gan Ibrahim Aldoss (15055961)

    Cyhoeddwyd 2025
    Awduron Eraill:
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... gan Ibrahim Aldoss (15055961)

    Cyhoeddwyd 2025
    Awduron Eraill:
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: